{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”
},
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”,
“headline”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“name”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“description”: “Detailed SOP describing sponsor, investigator, and regulatory responsibilities for ensuring compliance with ClinO and ClinO-MD regulations for clinical trial submissions and conduct in Switzerland under Swissmedic.”,
“keywords”: “Swissmedic ClinO SOP, SOP for ClinO compliance, SOP for ClinO-MD submissions, Swiss clinical trial submission SOP, SOP for regulatory compliance Switzerland, SOP for sponsor responsibilities Swissmedic, SOP for investigator site ClinO compliance, SOP for essential documents ClinO, SOP for safety reporting ClinO Swissmedic, SOP for trial approvals Switzerland, SOP for medical device ClinO-MD SOP, SOP for Swiss ethics submissions, SOP for inspection readiness Switzerland, SOP for bilingual documentation Switzerland, SOP for Swiss retention requirements, SOP for GCP compliance Swissmedic, SOP for protocol amendments Swissmedic, SOP for SUSAR reporting Switzerland, SOP for trial governance Switzerland, SOP for regulatory submissions Swissmedic, SOP for document archiving Switzerland, SOP for trial conduct ClinO, SOP for investigator brochure submissions Switzerland, SOP for trial governance ClinO Switzerland, SOP for compliance with Swiss regulations”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

ClinO and ClinO-MD Compliance in Submissions and Conduct SOP

Purpose

The purpose of this SOP is to define processes for ensuring compliance with the Swiss Ordinance on Clinical Trials in Human Research (ClinO) and the Ordinance on Clinical Trials with Medical Devices (ClinO-MD). It outlines the submission, approval, conduct, monitoring, and reporting requirements under Swissmedic, ensuring ethical and regulatory adherence.

Scope

This SOP applies to all clinical trials involving medicinal products and medical devices conducted in Switzerland under ClinO and ClinO-MD regulations. It covers sponsor obligations, investigator responsibilities, ethics committee submissions, safety reporting, amendments, and archiving of trial documents.

Responsibilities

• Sponsor: Ensures compliance with ClinO and ClinO-MD requirements, prepares submission dossiers, and maintains oversight.
• Regulatory Affairs (RA): Submits dossiers to Swissmedic and BASEC (ethics committee) and tracks approvals.
• Principal Investigator (PI): Conducts trials per ClinO/ClinO-MD, maintains documentation, and ensures subject safety.
• Clinical Project Manager (CPM): Coordinates timelines and ensures trial conduct is aligned with approvals.
• Quality Assurance (QA): Audits trial documents and processes to ensure readiness for inspections.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for compliance with ClinO/ClinO-MD obligations. The PI is accountable for site-level adherence and subject protection.

Procedure

1. Preparation of Submission Dossier

1. Compile CTA dossier including protocol, Investigator’s Brochure, ICF, IMPD (for drugs), or device dossier (for medical devices).
2. Ensure translations into German, French, or Italian as required.
3. Maintain Submission Checklist (Annexure-1).

2. Submissions to Swissmedic and BASEC

1. Submit dossiers electronically through Swissmedic and BASEC portals.
2. Record submission acknowledgments in Submission Log.

3. Trial Conduct and Monitoring

1. Conduct trial in compliance with ClinO/ClinO-MD, GCP, and local ethics requirements.
2. Maintain Trial Master File (TMF) with all essential documents.

4. Safety Reporting

1. Submit SUSARs to Swissmedic and BASEC within required timelines.
2. Report annual safety updates (DSURs) to authorities.

5. Protocol Amendments

1. Submit substantial amendments to Swissmedic and BASEC prior to implementation.
2. Record approvals in Amendment Log (Annexure-2).

6. Archiving

1. Archive TMF and ISF records for at least 10 years or as per ClinO retention requirements.

Abbreviations

• ClinO: Ordinance on Clinical Trials in Human Research
• ClinO-MD: Ordinance on Clinical Trials with Medical Devices
• Swissmedic: Swiss Agency for Therapeutic Products
• BASEC: Business Administration System for Ethics Committees
• CTA: Clinical Trial Application
• ICF: Informed Consent Form
• IMPD: Investigational Medicinal Product Dossier
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CPM: Clinical Project Manager
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Submission Checklist (Annexure-1)
2. Amendment Log (Annexure-2)
3. Safety Reporting Log (Annexure-3)

References

• Swissmedic — Clinical Trials
• BASEC — Ethics Committees Switzerland
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Submission Checklist

Annexure-2: Amendment Log

Annexure-3: Safety Reporting Log

Revision History

For more SOPs visit: Pharma SOP.